ACTIGRAPH LLC.

Company Snapshot

Founded: 2004
Entity Type: Private
Region: U.S.
Headquarter: U.S.
Key Geographics: North America
Corporate Address: 70 North Baylen Street Suite 400 Pensacola Florida 32502 U.S. Tel. +1-850-332-7900 www.theactigraph.com

Company Overview

ActiGraph LLC. is a Florida-based wearable medical technology company established in 2004. ActiGraph is the global research community’s trusted advisor and most experienced provider of medical-grade biometric monitoring technology solutions. Manufactured with more than 20 years of real-world data capture expertise, ActiGraph’s wearable accelerometer-based biosensors and innovative technology platform deliver validated digital biomarker data and end-to-end study support services for academic and pharmaceutical research. ActiGraph is the most popular brand of medical-grade devices, having been included in over 24,000 peer-reviewed scientific articles, utilized in over 230 clinical studies and sold in over 150 countries. Because of ActiGraph’s widespread use, the company has conducted significant validation testing on its products and created a range of algorithms that use the acceleration data obtained to infer relevant results relating to mobility, sleep and physical activity.

ACTIGRAPH LLC. In Reports

Digital Biomarkers: Global Markets

BCC Research Market Analyst says global market for digital biomarkers is estimated to grow from $5 billion in 2025 to $18.8 billion by the end of 2030.

Wearable Medical Devices: Technologies and Global Markets

BCC Research Market Analyst says global market for wearable medical devices was valued at $35.6 billion in 2023 & estimated to grow from $45.0 billion in 2024 to $151.8 billion by the end of 2029.

Sleep Aids: Technologies and Global Markets

BCC Research Market Report for Sleep Aids Industry. Global sleep aid Market is estimated to increase from $89.6 bln to reach $125.3 bln by 2027 at CAGR of 6.9%.

Company's Business Segments

  • Algorithms & Measures : The company provides digital health technologies (DHTs), which are utilized to advance clinical measures across various areas of research and development. 
  • Usability Evaluation Program : Under this segment, the company offers a program that allows study teams to make data-driven decisions about integrating DHTs by conducting usability validation before customer trials.
  • CentrePoint Platform : This is the company's robust cloud software platform designed to collect, process, and manage real-world digital endpoint data in clinical investigations.
  • Wearable Devices : This segment offers medical-grade wearables designed and optimized for use in scientific research and clinical trials.

Applications/End User Industries

  • Healthcare
  • Medical-grade wearable devices
AI Sentiment